Jason Hulse Murray Sells 317 Shares of PACS Group (NYSE:PACS) Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 317 shares of PACS Group stock in a transaction on Monday, September 14th. The shares were sold at an average price of $45.03, for a total value of $14,274.51. Following the transaction, the chief executive officer owned 54,555,249 shares of the company’s stock, valued at $2,456,622,862.47. The trade was a 0.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total value of $476,226.67.
• On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total value of $396,098.36.
• On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The shares were sold at an average price of $43.33, for a total value of $206,164.14.
• On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total value of $1,046,238.93.
• On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total transaction of $984,943.68.
• On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The stock was sold at an average price of $42.56, for a total transaction of $858,562.88.
• On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The shares were sold at an average price of $42.94, for a total transaction of $1,021,242.02.
• On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The shares were sold at an average price of $42.39, for a total transaction of $1,024,015.23.
• On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The stock was sold at an average price of $43.90, for a total transaction of $2,600,811.60.
• On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The stock was sold at an average price of $43.92, for a total transaction of $4,010,159.52.

PACS Group Trading Down 5.7%

Shares of NYSE PACS opened at $42.01 on Wednesday. The firm’s 50 day moving average price is $44.71 and its 200-day moving average price is $39.13. The company has a market cap of $6.65 billion, a PE ratio of 24.42, a P/E/G ratio of 1.39 and a beta of -0.13. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.49. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91.

PACS Group (NYSE:PACS) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. On average, equities research analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Trending Headlines about PACS Group

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Wall Street remains constructive on PACS Group. Truist Financial, Oppenheimer, UBS, and JPMorgan have assigned price targets ranging from $57 to $62, while the reported consensus target is $58.80 versus recent trading levels. Analysts cite the company’s growth outlook and maintain an overall “Moderate Buy” rating. PACS Group insider trading and analyst coverage
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.63 versus the $0.54 consensus estimate and revenue of $1.43 billion versus $1.41 billion expected. This supports the case for continued earnings growth in PACS Group’s skilled-nursing and post-acute-care operations.
• Neutral Sentiment: PACS Group presented at the 2026 Jefferies Healthcare Services and Technology Conference on September 15. Management discussed operations and its growth strategy, but the announcement did not disclose new financial guidance or a material business update. PACS Group Jefferies conference announcement
• Negative Sentiment: Director Mark Hancock sold 300,000 shares across September 14–15 for roughly $13.0 million, while CEO Jason Murray sold more than 10,000 shares in the latest reported transactions. The sales add near-term supply and may concern investors, although Hancock and Murray still retain more than 53 million and 54 million shares, respectively; the reported sales represent only small reductions in their holdings. PACS Group director insider sale filing

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Financial Management Professionals Inc. increased its stake in PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after buying an additional 235 shares in the last quarter. Jacobsen Capital Management lifted its position in shares of PACS Group by 1.6% in the first quarter. Jacobsen Capital Management now owns 18,128 shares of the company’s stock valued at $582,000 after acquiring an additional 294 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of PACS Group by 127.0% in the fourth quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock valued at $42,000 after acquiring an additional 612 shares in the last quarter. Strategic Advocates LLC boosted its stake in shares of PACS Group by 18.5% in the fourth quarter. Strategic Advocates LLC now owns 5,182 shares of the company’s stock worth $203,000 after acquiring an additional 808 shares during the period. Finally, Peterson Wealth Services boosted its stake in shares of PACS Group by 1.6% in the first quarter. Peterson Wealth Services now owns 53,672 shares of the company’s stock worth $1,724,000 after acquiring an additional 854 shares during the period.

Wall Street Analyst Weigh In

A number of analysts have recently commented on PACS shares. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. Weiss Ratings cut shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Oppenheimer boosted their target price on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Finally, UBS Group increased their price target on PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $58.80.

About PACS Group

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.